Antitumoral activity of allosteric inhibitors of protein kinase CK2.
about
Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive LeukemiasStrength and specificity of the CMBA screening platform for bioactive molecules discoveryA subnanomolar fluorescent probe for protein kinase CK2 interaction studiesCasein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathwayIdentification of a Potent Allosteric Inhibitor of Human Protein Kinase CK2 by Bacterial Surface Display Library Screening.CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma.Crosstalk between casein kinase II and Ste20-related kinase Nak1.Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model.Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.Protein kinase CK2 inhibitors: a patent review.Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specific cell-permeable peptide inhibitor.Casein kinases as potential therapeutic targets.Inhibition of protein kinase II (CK2) prevents induced signal transducer and activator of transcription (STAT) 1/3 and constitutive STAT3 activation.Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells.Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'.
P2860
Q26769590-A8D58564-F381-4C38-83D4-0E70B7589CCCQ27014820-E715F416-D5D0-432B-98D0-3A944A7CD268Q27682639-1CF97846-4E95-497B-BEA5-B859F363D86CQ35205600-8F25CC73-313D-4B82-8207-E15BE9517B37Q36244285-3ADA4178-C503-4691-819C-867122720EE2Q36263671-532E8E8E-72EC-4A49-AE72-7413A9499070Q36544222-6A7BB013-4A02-48DF-99B9-56978B029FB1Q36798054-5CCE3124-60E3-4E75-92D2-EA36F0A7C1B0Q37296057-9D8BD6F2-3708-40CF-A8FB-0C7736533F1BQ37599312-E070F026-0335-4C53-BFAF-24C11376065FQ38036342-58427A57-6963-4C26-8F7D-2A99D6EE5485Q38365378-3CE2ADBF-C84D-446F-8D57-BBF59133A606Q38632634-89B12E71-7A7C-456B-8463-5FDCD9DE3A9FQ39003208-1DA105E9-F873-466F-89CD-7BF6D670C573Q39176046-18AFA566-702D-425D-A7C5-10BBA74BAD1AQ46490579-22C59A27-AC3F-465F-BAD7-38FC921D5457Q47162634-11A7C3FB-430B-4488-8DEA-2DA469F3A479
P2860
Antitumoral activity of allosteric inhibitors of protein kinase CK2.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antitumoral activity of allosteric inhibitors of protein kinase CK2.
@ast
Antitumoral activity of allosteric inhibitors of protein kinase CK2.
@en
Antitumoral activity of allosteric inhibitors of protein kinase CK2.
@nl
type
label
Antitumoral activity of allosteric inhibitors of protein kinase CK2.
@ast
Antitumoral activity of allosteric inhibitors of protein kinase CK2.
@en
Antitumoral activity of allosteric inhibitors of protein kinase CK2.
@nl
prefLabel
Antitumoral activity of allosteric inhibitors of protein kinase CK2.
@ast
Antitumoral activity of allosteric inhibitors of protein kinase CK2.
@en
Antitumoral activity of allosteric inhibitors of protein kinase CK2.
@nl
P2093
P2860
P356
P1433
P1476
Antitumoral activity of allosteric inhibitors of protein kinase CK2
@en
P2093
Céline F Sautel
Florence Teillet
Laurence Lafanechere
Renaud Prudent
Veronique Receveur-Brechot
Virginie Moucadel
P2860
P304
P356
10.18632/ONCOTARGET.361
P407
P577
2011-12-01T00:00:00Z